Key result
Favipiravir binds SARS-CoV-2 polymerase via unexpected base-pairing mimicking both adenine and guanine.
Why the study?
Favipiravir can serve as a broad-spectrum antiviral against SARS-CoV-2, but the structural basis of its incorporation into replicating coronavirus polymerase complexes was uncharacterized.
The cryo-EM structure of Favipiravir bound to the SARS-CoV-2 polymerase reveals its mechanism of mimicking purine nucleotides, providing a structural basis for antiviral drug development.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for favipiravir analogs; leaves open translation to improved clinical antivirals.
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into an unprecedented global pandemic. Nucleoside analogues, such as Remdesivir and Favipiravir, can serve as the first-line broad-spectrum antiviral drugs against the newly emerging viral diseases. Recent clinical trials of these two drugs for SARS-CoV-2 treatment revealed antiviral efficacies as well as side effects with different extents 1–4 . As a pyrazine derivative, Favipiravir could be incorporated into the viral RNA products by mimicking both adenine and guanine nucleotides, which may further lead to mutations in progeny RNA copies due to the non-conserved base-pairing capacity 5 . Here, we determined the cryo-EM structure of Favipiravir bound to the replicating polymerase complex of SARS-CoV-2 in the pre-catalytic state. This structure provides a missing snapshot for visualizing the catalysis dynamics of coronavirus polymerase, and reveals an unexpected base-pairing pattern between Favipiravir and pyrimidine residues which may explain its capacity for mimicking both adenine and guanine nucleotides. These findings shed lights on the mechanism of coronavirus polymerase catalysis and provide a rational basis for developing antiviral drugs to combat the SARS-CoV-2 pandemic.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2020) studied SARS-CoV-2. Favipiravir was evaluated on Cryo-EM structure of SARS-CoV-2 polymerase bound to Favipiravir. Favipiravir binds to the SARS-CoV-2 polymerase complex in the pre-catalytic state, revealing an unexpected base-pairing pattern that explains its capacity to mimic both adenine and guanine.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: